News of the drug world

News and points of interest from the sector of health care are prepared for you.

  • List of reimbursed medicinal products valid as of 1.10.2016 Detail

    Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended, the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes.


  • PSUR Repository Detail

    The PSUR Repository is now available and it offers a secure electronic submission point for Marketing Authorisation Holders (MAH), streamlining the Periodic Safety Update Report (PSUR) submissions for the pharmaceutical industry.


  • Public-friendly information on herbal medicines now available Detail

    From now on the European Medicines Agency (EMA) will systematically publish summaries of the recommendations of its Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of an herbal substance in easy to understand, public-friendly language. 


  • ATB resistance genes found in bacteria Detail

    Scientists have discovered antibiotic resistance genes in the bacteria of remote S. American tribe who have had no contact with the industrialized world or exposure to antibiotic drugs.


  • Prevention of medication errors in the EU Detail

    The European Medicines Agency (EMA), has released two draft good practice guides that aim to improve the reporting, evaluation and prevention of medication errors by regulatory authorities and pharmaceutical industry throughout the EU.


  • Mandatory use of electroning application forms soon Detail

    The European Medicines Agency (EMA) is announcing the transition to the mandatory use of electronic application forms for initial marketing authorisations, variations and renewals for human and veterinary medicines.


  • EU Notified Bodies Update Code of Conduct Detail

    The European Association for Medical Devices of Notified Bodies (Team-NB) has published an updated Code of Conduct targeting more consistent and transparent CE Mark certifications from member firms.


  • Discussions on system of pediatric trials’ regulation Detail

    Cancer experts say that current system of regulations of children's cancer drug trials should be changed. They argue that the current system denies children new, potentially life-saving drugs and that children could have access to drugs that are currently only being tested in adults. 


  • Idea of a joint clinical study Detail

    The DIA (Drug Information Association) specialists have discussed the possibility of cooperation of more pharmaceutical companies within the scope of a single clinical study.


  • EMA news Detail

    EMA policy to publishing and access to the data from clinical studies.


  • New subject Detail

    For the autumn semester the RECAMO Centre and the Institute of Pharmacology of the Faculty of Medicine of Masaryk University has prepared a new subject for postgraduate students of the Faculty of Medicine and Faculty of Science of Masaryk University focused on development of medicinal products.


  • Lectures are opening Detail

    Materials from the opening lecture already available! All events are without registration fee.



Register for receiving PharmaAround news, register for PharmAround events.
Continue registration

Recently visited